Bonfill, XavierMartinez-Zapata, María JoséVernooij, Robin WmSánchez, María JoséMorales-Suárez-Varela, MaríaEmparanza, José IgnacioFerrer, MontsePijoan, José IgnacioPalou, JoanMadrid, EvaAbraira, VíctorZamora, JavierEMPARO-CU study group2025-01-072025-01-072021https://hdl.handle.net/10668/24665The therapeutic approach is crucial to prostate cancer prognosis. We describe treatments and outcomes for a Spanish cohort of patients with prostate cancer during the first 12 months after diagnosis and identify the factors that influenced the treatment they received.This multicenter prospective cohort study included patients with prostate cancer followed up for 12 months after diagnosis. Treatment was stratified by factors such as hospital, age group (enAttribution-NonCommercial 4.0 Internationalhttp://creativecommons.org/licenses/by-nc/4.0/AftercareAgedAntineoplastic Agents, HormonalBrachytherapyChemotherapy, AdjuvantCohort StudiesHumansMaleNeoplasm GradingProspective StudiesProstate-Specific AntigenProstatectomyProstatic NeoplasmsSpainTreatment Outcomeresearch article34964747open access10.1097/MD.00000000000278011536-5964PMC8615301https://doi.org/10.1097/md.0000000000027801https://pmc.ncbi.nlm.nih.gov/articles/PMC8615301/pdf